SHORT-TERM EFFECTS OF ESTROGEN AND PROGESTIN ON BLOOD-PRESSURE OF NORMOTENSIVE POSTMENOPAUSAL WOMEN

被引:24
作者
REGENSTEINER, JG
HIATT, WR
BYYNY, RL
PICKETT, CK
WOODARD, WD
MOORE, LG
机构
[1] UNIV COLORADO,HLTH SCI CTR,DIV GEN INTERNAL MED,DENVER,CO 80262
[2] UNIV COLORADO,HLTH SCI CTR,DEPT MED,DIV CLIN PHARMACOL,DENVER,CO 80262
[3] UNIV COLORADO,HLTH SCI CTR,DEPT OBSTET & GYNECOL,DENVER,CO 80262
[4] UNIV COLORADO,DEPT ANTHROPOL,DENVER,CO 80202
关键词
D O I
10.1002/j.1552-4604.1991.tb03735.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Blood pressure rises in women with increasing age, possibly related to the decrease in production of female hormones that accompanies menopause. Although estrogen or progestin administration alone consistently does not lower blood pressure in postmenopausal women, possible interactions of these two hormones in affecting blood pressure are not well understood. We studied 12 surgically postmenopausal, normotensive women, aged 51 +/- 2 years (SEM). Treatment for each subject consisted of 1 week each of placebo, estrogen (conjugated equine estrogens, 2.5 mg/day), progestin (medroxyprogesterone acetate, 60 mg/day), and combined estrogen and progestin, given in varied order. At the end of each week, auscultatory blood pressures were measured while patients were seated. Neither estrogen nor progestin alone either increased or decreased blood pressure significantly, whereas combined estrogen and progestin lowered systolic, diastolic, and mean blood pressures 6 to 7 mm Hg (P < .05). Treatment order was unrelated to the change in blood pressure values. The authors suggest that administering progestin with estrogen may be more effective in lowering blood pressure than either hormone alone in postmenopausal women.
引用
收藏
页码:543 / 548
页数:6
相关论文
共 32 条
[1]  
Amos SE, 1922, LANCET, V2, P956
[2]   USE OF POST-MENOPAUSAL HORMONES AND RISK OF MYOCARDIAL-INFARCTION [J].
BAIN, C ;
WILLETT, W ;
HENNEKENS, CH ;
ROSNER, B ;
BELANGER, C ;
SPEIZER, FE .
CIRCULATION, 1981, 64 (01) :42-46
[3]   ESTROGEN USE AND ALL-CAUSE MORTALITY - PRELIMINARY-RESULTS FROM THE LIPID RESEARCH CLINICS PROGRAM FOLLOW-UP-STUDY [J].
BUSH, TL ;
COWAN, LD ;
BARRETTCONNOR, E ;
CRIQUI, MH ;
KARON, JM ;
WALLACE, RB ;
TYROLER, HA ;
RIFKIND, BM .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 249 (07) :903-906
[4]   DOSE-RESPONSE EVALUATION OF CYCLIC ESTROGEN GESTAGEN IN POST-MENOPAUSAL WOMEN - PLACEBO-CONTROLLED TRIAL OF ITS GYNECOLOGIC AND METABOLIC ACTIONS [J].
CHRISTENSEN, MS ;
HAGEN, C ;
CHRISTIANSEN, C ;
TRANSBOL, I .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1982, 144 (08) :873-879
[5]   PREVENTION OF EARLY POST-MENOPAUSAL BONE LOSS - CONTROLLED 2-YEAR STUDY IN 315 NORMAL FEMALES [J].
CHRISTIANSEN, C ;
CHRISTENSEN, MS ;
MCNAIR, P ;
HAGEN, C ;
STOCKLUND, K ;
TRANSBOL, IB .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1980, 10 (04) :273-279
[6]   EFFECTS OF NATURAL ESTROGEN-GESTAGEN AND THIAZIDE ON CORONARY RISK-FACTORS IN NORMAL POST-MENOPAUSAL WOMEN - A 2-YEAR DOUBLE-BLIND PLACEBO STUDY [J].
CHRISTIANSEN, C ;
CHRISTENSEN, MS ;
HAGEN, C ;
STOCKLUND, KE ;
TRANSBOL, I .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1981, 60 (04) :407-412
[7]   MEASUREMENT OF MEDROXYPROGESTERONE ACETATE (PROVERA1) BY RADIOIMMUNOASSAY [J].
CORNETTE, JC ;
KIRTON, KT ;
DUNCAN, GW .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1971, 33 (03) :459-+
[8]   HYPERTENSION, ORAL CONTRACEPTIVE AGENTS, AND CONJUGATED ESTROGENS [J].
CRANE, MG ;
HARRIS, JJ ;
WINSOR, W .
ANNALS OF INTERNAL MEDICINE, 1971, 74 (01) :13-+
[9]   CHANGES IN APOLIPOPROTEIN-A-I AFTER TREATMENT WITH HIGH-DOSE MEDROXYPROGESTERONE ACETATE [J].
CRONA, N ;
ENK, L ;
FRIBERG, LG ;
SAMSIOE, G ;
SILFVERSTOLPE, G .
GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1984, 18 (01) :16-20
[10]  
EIFF AWV, 1971, AM J OBSTET GYNECOL, V109, P887